Answers are grounded in this paper and cite their sources.
HPV test results describe detection at a sampled site and time, but do not establish whether an infection has been eradicated. Existing latency models already accommodate basal epithelial persistence, immune control, and later reactivation. We use restricted persistent infection as an operational refinement of these concepts: retention of replication-capable HPV genomes in a defined epithelial compartment without demonstrated sustained productive infection. Human tissue studies have detected focal HPV DNA in cervices without evidence of productive or transforming lesions, although they have not established a continuous link between intact episomes, the cells carrying them, and later reactivation. Animal experiments and cell-based studies address different parts of this mechanism and are assessed separately. The framework distinguishes biological states from observed test results, separates productive infection from intermittent DNA detection, and specifies competing explanations for type-specific redetection. We propose complementary tissue-localization, genome-structure, and functional assays, together with longitudinal sampling and exposure assessment. Viral continuity would be assessed through whole-genome sequencing, repeated sampling, tissue localization, and exposure histories. Quantitative study examples define the populations, detection performance, and event frequencies against which particular predictions could be tested. Tissue studies would estimate the prevalence of retained replication-capable genomes, while longitudinal studies would assess their relationship to subsequent type-specific redetection.
No takes yet. Share an insight, caveat, or question.
Zhai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: